Bruker Corp. (BRKR) Misses Q2 EPS by 1c; Sees Exceeds High-End of FY11 Revs Outlook
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $77.63 -6.4%
Revenue Growth %: +6.6%
Financial Fact:
Gross profit: 185.2M
Today's EPS Names:
ESCA, LICT, NKSH, More
Revenue Growth %: +6.6%
Financial Fact:
Gross profit: 185.2M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Bruker Corporation (NASDAQ: BRKR) reported Q2 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $401.2 million versus the consensus estimate of $384.11 million.
Sees exceeding high-end of FY11 revs outlook by $30 to $50 million.
Sees exceeding high-end of FY11 revs outlook by $30 to $50 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
- Las Vegas Sands (LVS) stock slips despite earnings, revenue beat in Q1
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
